Wealthcare Advisory Partners LLC increased its position in Edwards Lifesciences Co. (NYSE:EW – Get Rating) by 10.8% in the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 10,350 shares of the medical research company’s stock after acquiring an additional 1,011 shares during the […]
Clear Street Markets LLC raised its position in shares of Edwards Lifesciences Co. (NYSE:EW – Get Rating) by 229.9% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 4,655 shares of the medical research company’s stock after purchasing […]
Natixis cut its stake in Edwards Lifesciences Co. (NYSE:EW – Get Rating) by 26.0% in the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 115,933 shares of the medical research company’s stock after selling 40,643 shares during the period. Natixis’ holdings in […]
Brown Advisory Inc. raised its stake in shares of Edwards Lifesciences Co. (NYSE:EW – Get Rating) by 0.8% during the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 14,341,102 shares of the medical research company’s stock after acquiring an additional 115,268 […]
Ossiam lowered its stake in shares of Edwards Lifesciences Co. (NYSE:EW – Get Rating) by 5.1% during the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 25,475 shares of the medical research company’s stock after selling 1,374 shares during the period. Ossiam’s holdings […]